Titus B. Ball Sells $47K of BeOne Medicines Ltd (ONC) — SEC Form 4, Sep 03, 2026

Open-Market Net Sale · SEC Form 4
−$46,974

Equity position changed by -0.1%

Reporting Owner
TXN 2026-09-01 · FILED 2026-09-03
Equity Position 97.9K sh 98,061 → 97,929
Equity Change -0.1% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-03
Report Date
2026-09-03
Accession No.
0001675628-26-000003
Accepted At
2026-09-03 21:17 UTC
Reporting Owner
Name Relationship
Titus B. Ball CIK 0001675628
CAO
Titus B. Ball at BeOne Medicines Ltd Full insider history
Bought (12 mo) —
Sold (12 mo) $759,619
More from this insider at BeOne Medicines Ltd
2026-11-10 Sell -$632,277 View
2026-06-15 Sell -$43,467 View
2026-06-10 Sell -$36,901 View
2025-09-04 Sell -$39,864 View
2025-06-12 Sell -$34,620 View
All filings by this insider at BeOne Medicines Ltd
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
American Depositary SharesF1F2 2026-09-01 S - Sale 132 D $355.86 -$46,974 0 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Ordinary Shares 97,929 Direct
Footnotes (2)
F1
Each American Depositary Share represents 13 Ordinary Shares. Show more
F2
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. Show more
5%+ Holders · 13D/G 2 filers
Other insiders at BeOne Medicines Ltd
All BeOne Medicines Ltd insider activity
GET /v1/forms/4/0001675628-26-000003 API docs
View Original SEC Filing